CCI clears Integrace’s proposed Universal Nutriscience transaction

The Competition Commission of India has approved Integrace Private Limited’s proposed acquisition of share capital in Universal Nutriscience Private Limited and a related transaction. The regulator announced its decision on October 22.

Integrace focuses on domestic formulations in orthopaedics and gynaecology, with more than 20 products spanning pain management, pregnancy and women’s health. Universal Nutriscience focuses on nutraceutical and lifestyle products. Integrace is a subsidiary of Morning Waves Investments B.V., an affiliate of Warburg Pincus and/or its affiliates, according to the release.

The clearance concerns competition approval for the proposed transaction. The announcement does not disclose its value, the percentage stake being acquired or a completion date; it should not be read as confirmation that the acquisition has closed.